MONOFERRIC® (ferric derisomaltose for injection) is indicated for:
- the treatment of iron deficiency anemia in adult patients who have intolerance or unresponsiveness to oral iron therapy.
The diagnosis must be based on laboratory tests.
Pediatrics (< 18 years of age): No data are available to Health Canada; therefore, Health Canada has not authorized an indication for pediatric use.
A careful risk benefit assessment is required before MONOFERRIC is used in patients aged > 65 years and close monitoring for adverse events is required (see 7 WARNINGS AND PRECAUTIONS, Special Populations, Geriatrics).